PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF 3-MONTH LYMECYCLINE TREATMENT ON SERUM MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS

LAUHIO A, KONTTINEN YT, SALO T, Tschesche H, LAHDEVIRTA J, WOESSNER F, GOLUB LM, SORSA T (1994)
In: INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL. Annals of the New York Academy of Sciences, 732(1 Inhibition of). NEW YORK ACAD SCIENCES: 424-426.

Konferenzbeitrag | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
DOI
Autor*in
LAUHIO, A; KONTTINEN, YT; SALO, T; Tschesche, HaraldUniBi; LAHDEVIRTA, J; WOESSNER, F; GOLUB, LM; SORSA, T
Einrichtung
Fakultät für Chemie > Biochemie I
Erscheinungsjahr
1994
Titel des Konferenzbandes
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL
Serien- oder Zeitschriftentitel
Annals of the New York Academy of Sciences
Band
732
Ausgabe
1 Inhibition of
Seite(n)
424-426
ISSN
0077-8923
Page URI
https://pub.uni-bielefeld.de/record/1640745

Zitieren

LAUHIO A, KONTTINEN YT, SALO T, et al. PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF 3-MONTH LYMECYCLINE TREATMENT ON SERUM MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS. In: INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL. Annals of the New York Academy of Sciences. Vol 732. NEW YORK ACAD SCIENCES; 1994: 424-426.
LAUHIO, A., KONTTINEN, Y. T., SALO, T., Tschesche, H., LAHDEVIRTA, J., WOESSNER, F., GOLUB, L. M., et al. (1994). PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF 3-MONTH LYMECYCLINE TREATMENT ON SERUM MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, Annals of the New York Academy of Sciences, 732, 424-426. NEW YORK ACAD SCIENCES. https://doi.org/10.1111/j.1749-6632.1994.tb24774.x
LAUHIO, A, KONTTINEN, YT, SALO, T, Tschesche, Harald, LAHDEVIRTA, J, WOESSNER, F, GOLUB, LM, and SORSA, T. 1994. “PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF 3-MONTH LYMECYCLINE TREATMENT ON SERUM MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS”. In INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 732:424-426. Annals of the New York Academy of Sciences. NEW YORK ACAD SCIENCES.
LAUHIO, A., KONTTINEN, Y. T., SALO, T., Tschesche, H., LAHDEVIRTA, J., WOESSNER, F., GOLUB, L. M., and SORSA, T. (1994). “PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF 3-MONTH LYMECYCLINE TREATMENT ON SERUM MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS” in INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL Annals of the New York Academy of Sciences, vol. 732, (NEW YORK ACAD SCIENCES), 424-426.
LAUHIO, A., et al., 1994. PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF 3-MONTH LYMECYCLINE TREATMENT ON SERUM MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS. In INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL. Annals of the New York Academy of Sciences. no.732 NEW YORK ACAD SCIENCES, pp. 424-426.
A. LAUHIO, et al., “PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF 3-MONTH LYMECYCLINE TREATMENT ON SERUM MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS”, INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, Annals of the New York Academy of Sciences, vol. 732, NEW YORK ACAD SCIENCES, 1994, pp.424-426.
LAUHIO, A., KONTTINEN, Y.T., SALO, T., Tschesche, H., LAHDEVIRTA, J., WOESSNER, F., GOLUB, L.M., SORSA, T.: PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF 3-MONTH LYMECYCLINE TREATMENT ON SERUM MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL. Annals of the New York Academy of Sciences. 732, p. 424-426. NEW YORK ACAD SCIENCES (1994).
LAUHIO, A, KONTTINEN, YT, SALO, T, Tschesche, Harald, LAHDEVIRTA, J, WOESSNER, F, GOLUB, LM, and SORSA, T. “PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF 3-MONTH LYMECYCLINE TREATMENT ON SERUM MATRIX METALLOPROTEINASES IN REACTIVE ARTHRITIS”. INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL. NEW YORK ACAD SCIENCES, 1994.Vol. 732. Annals of the New York Academy of Sciences. 424-426.

1 Zitation in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

The dynamic sclera: extracellular matrix remodeling in normal ocular growth and myopia development.
Harper AR, Summers JA., Exp Eye Res 133(), 2015
PMID: 25819458

5 References

Daten bereitgestellt von Europe PubMed Central.


Lauhio, Arthritis Rheum 24(), 1991
The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis.
Lauhio A, Sorsa T, Lindy O, Suomalainen K, Saari H, Golub LM, Konttinen YT., Arthritis Rheum. 35(2), 1992
PMID: 1310409
Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage.
Greenwald RA, Moak SA, Ramamurthy NS, Golub LM., J. Rheumatol. 19(6), 1992
PMID: 1404131
Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline.
Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA., Arthritis Rheum. 35(10), 1992
PMID: 1329773
The regulatory role of doxycycline/tetracycline in collagenolytic activity and tissue destruction in joint diseases: comment on the article by Yu et al.
Lauhio A, Sorsa T, Lindy O, Suomalainen K, Saari H, Golub LM, Konttinen YT., Arthritis Rheum. 36(9), 1993
PMID: 8216431
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 7978828
PubMed | Europe PMC

Suchen in

Google Scholar